Cervical Cancer and HPV Research

Cervical cancer is caused almost entirely by persistent infection with certain strains of Human Papillomavirus, making it one of the few common cancers with a well-understood infectious origin and, consequently, a target for both vaccination and organized screening. Epidemiologists in this area track how HPV genotypes vary across populations, how vaccination programs are reshaping cancer incidence over time, and where gaps in cytology-based screening leave women at continued risk — questions that matter most in low- and middle-income countries, where the global burden is concentrated. Two active directions are understanding how viral oncoproteins drive malignant transformation at the molecular level and evaluating whether current vaccines provide sufficient cross-protection against less common but still carcinogenic HPV types. Integrating genomic surveillance with real-world screening data remains an open methodological challenge as researchers try to measure the full population-level impact of prevention efforts.

Works

154,519

Total citations

2,041,973

Keywords

Human PapillomavirusCervical CancerHPV VaccinationEpidemiologyCancer IncidenceCytology Screening